Candriam S.C.A. Has $88.20 Million Holdings in Danaher Corporation $DHR

Candriam S.C.A. decreased its stake in shares of Danaher Corporation (NYSE:DHR) by 1.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 444,856 shares of the conglomerate’s stock after selling 7,077 shares during the quarter. Candriam S.C.A.’s holdings in Danaher were worth $88,197,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. White Pine Capital LLC grew its holdings in shares of Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after purchasing an additional 49 shares in the last quarter. SOL Capital Management CO lifted its position in Danaher by 2.8% in the third quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock worth $363,000 after purchasing an additional 50 shares during the period. Purkiss Capital Advisors LLC boosted its stake in Danaher by 3.9% during the third quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock worth $263,000 after buying an additional 50 shares in the last quarter. Boyd Watterson Asset Management LLC OH increased its holdings in Danaher by 2.1% in the 2nd quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock valued at $499,000 after buying an additional 51 shares during the period. Finally, Howard Capital Management Group LLC raised its stake in shares of Danaher by 4.8% in the 3rd quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock valued at $230,000 after buying an additional 53 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 0.5%

Shares of DHR opened at $216.77 on Monday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.51 and a current ratio of 1.87. The company has a market cap of $153.12 billion, a price-to-earnings ratio of 43.01, a PEG ratio of 2.93 and a beta of 0.91. The stock has a fifty day moving average price of $229.62 and a two-hundred day moving average price of $215.17. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The company had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same period last year, the company posted $2.14 earnings per share. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. Analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio is 25.40%.

Insider Buying and Selling

In other news, Director Teri List sold 3,298 shares of Danaher stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total value of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares of the company’s stock, valued at approximately $4,702,593. This trade represents a 13.71% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of the company’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total value of $4,773,952.48. Following the transaction, the senior vice president directly owned 14,553 shares in the company, valued at $3,190,454.19. This trade represents a 59.94% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 11.20% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on DHR. TD Cowen reissued a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a report on Thursday, January 29th. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a report on Saturday, November 22nd. Jefferies Financial Group raised their target price on Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, Guggenheim upped their price target on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, January 2nd. Twenty research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.